Skip to content

Ultrasound Study by Texturization as a Predictor of Pregnancy in Oocyte Donation Programs

Ultrasound Study Through Uterine Texturization to Predict Pregnancy After Blastocyst Transfer in Patients Undergoing Hormone Replacement Therapy (HRT) Cycles With Donor Oocytes

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03507322
Acronym
TEXTUGEST
Enrollment
0
Registered
2018-04-25
Start date
2017-11-07
Completion date
2018-09-10
Last updated
2018-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

texturization, pregnancy rate, oocyte donation, 2D ultrasound, 3D ultrasound, assisted reproductive technology (ART)

Brief summary

This study is focused on analysing the application of ultrasound scanning techniques as new biomarkers in reproductive medicine. Those biomarkers are based on the analysis of ultrasound texture in different areas of uterine tissue, using 2D/3D ultrasound scanning. Investigators will use the algorithm Text® to analyse the ultrasound texture of the endometrium and myometrium. The aim of the project is to study if it is possible to obtain measurable, objective and reproducible data in healthy volunteers which can be used to predict pregnancy and determine the best moment to perform embryo transfer in assisted reproductive technology (ART) cycles

Interventions

OTHERUltrasound texturization

Along several visits to the clinic, the patients will be subjected to 2D/3D ultrasound scanning.

Sponsors

Vida Recoletas Sevilla
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

* Body mass index (BMI) between 18 and 30 kg/m2 * Not taking the contraceptive pill in a previous cycle * Non-pregnant: beta human chorionic gonadotropin (HCG) test with negative result at the beginning of the study) * No previous history of inflammatory diseases, circulatory diseases, abdomen or pelvic diseases * Physical gynecological exploration without pathological findings * Gynecological ultrasound study of the uterus with a normal result

Exclusion criteria

* Ultrasound studies with technical defects in image acquisition * Simultaneous participation in other studies * Previous participation in other study which can affect the results of the present study

Design outcomes

Primary

MeasureTime frameDescription
Clinical pregnancy rateAround 5-6 weeks after embryo transferDetection of gestational sac through ultrasound scanning indicating clinical pregnancy
Biochemical miscarriage rateUp to one month after embryo transferInterruption of pregnancy after a positive result in the beta HCG test
Clinical miscarriage rateUp to 20 weeks after embryo transferInterruption of pregnancy after confirming clinical pregnancy using ultrasound scanning
Chemical pregnancy rateAround 14 days after embryo transferPositive result in beta HCG test indicating pregnancy
beta HCG levelAround 14 days after embryo transferLevel of beta HCG in the test performed to detect pregnancy

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026